A new Food and Drug Administration (FDA) plan to revamp—and in some cases, drop—rules on how to deal with overlapping drug, device, and biologic products could give the agency an upper hand when challenged over how it classifies them.
Learn more about AAPS Journals and Books
The AAPS Journal
Publishes novel and significant findings in the various areas of pharmaceutical sciences.
AAPS PharmSciTech
Presents papers related to pharmaceutical dosage forms and delivery systems, including drugs derived from biotechnology.
Pharmaceutical Research
Publishes innovative research on drug discovery, development, evaluation, and regulatory approval.
AAPS OpenProvides a global forum for the rapid and barrier-free publication of reports of original research
To read the full content, please log in with your AAPS member username and password.
Sign InNot a member? Learn more and join today!
Contact Us:
Kristen Kalmann, Content Manager 2107 Wilson Blvd. Ste. 200 Arlington, VA 22201
Advertising
Kira Krewson1-770-810-6982 View the Media Kit
AAPS Customer Service
1-703-243-2800